FACS-based genome-wide CRISPR screening platform identifies modulators of CD47
Cited by 1
Related Papers
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
|Nature Cancer|2023|219
Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47
|Nature Cancer|2024|94
SIRPα: A key player in innate immunity
|European Journal of Immunology|2023|23
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance
|Science Immunology|2025|19